129 related articles for article (PubMed ID: 12354757)
1. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
Bompard G; Puech C; Prébois C; Vignon F; Freiss G
J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
[TBL] [Abstract][Full Text] [Related]
2. The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.
Dromard M; Bompard G; Glondu-Lassis M; Puech C; Chalbos D; Freiss G
Cancer Res; 2007 Jul; 67(14):6806-13. PubMed ID: 17638892
[TBL] [Abstract][Full Text] [Related]
3. Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells.
Freiss G; Puech C; Vignon F
Mol Endocrinol; 1998 Apr; 12(4):568-79. PubMed ID: 9544992
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket.
Villa F; Deak M; Bloomberg GB; Alessi DR; van Aalten DM
J Biol Chem; 2005 Mar; 280(9):8180-7. PubMed ID: 15611135
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.
Kimber WA; Deak M; Prescott AR; Alessi DR
Biochem J; 2003 Dec; 376(Pt 2):525-35. PubMed ID: 14516276
[TBL] [Abstract][Full Text] [Related]
6. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
7. Regulation of TRP channel TRPM2 by the tyrosine phosphatase PTPL1.
Zhang W; Tong Q; Conrad K; Wozney J; Cheung JY; Miller BA
Am J Physiol Cell Physiol; 2007 May; 292(5):C1746-58. PubMed ID: 17251321
[TBL] [Abstract][Full Text] [Related]
8. Anti-growth factor activities of benzothiophenes in human breast cancer cells.
Freiss G; Galtier F; Puech C; Aknin C; Maudelonde T; Chalbos D; Vignon F
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):451-60. PubMed ID: 15876410
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells.
Li Y; Kanki H; Hachiya T; Ohyama T; Irie S; Tang G; Mukai J; Sato T
Int J Cancer; 2000 Aug; 87(4):473-9. PubMed ID: 10918185
[TBL] [Abstract][Full Text] [Related]
10. Fas-associated phosphatase-1 promotes Fas-mediated apoptosis in human colon cancer cells: novel function of FAP-1.
Miyazaki T; Atarashi Y; Yasumura S; Minatoya I; Ogawa K; Iwamoto M; Minemura M; Shimizu Y; Sato TA; Watanabe A; Sugiyama T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):84-91. PubMed ID: 16706817
[TBL] [Abstract][Full Text] [Related]
11. Identification of IkappaBalpha as a substrate of Fas-associated phosphatase-1.
Nakai Y; Irie S; Sato TA
Eur J Biochem; 2000 Dec; 267(24):7170-5. PubMed ID: 11106428
[TBL] [Abstract][Full Text] [Related]
12. FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface.
Ivanov VN; Lopez Bergami P; Maulit G; Sato TA; Sassoon D; Ronai Z
Mol Cell Biol; 2003 May; 23(10):3623-35. PubMed ID: 12724420
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
15. [PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers].
Freiss G; Bompard G; Vignon F
Bull Cancer; 2004 Apr; 91(4):325-32. PubMed ID: 15242314
[TBL] [Abstract][Full Text] [Related]
16. Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.
Meinhold-Heerlein I; Stenner-Liewen F; Liewen H; Kitada S; Krajewska M; Krajewski S; Zapata JM; Monks A; Scudiero DA; Bauknecht T; Reed JC
Am J Pathol; 2001 Apr; 158(4):1335-44. PubMed ID: 11290551
[TBL] [Abstract][Full Text] [Related]
17. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.
Glondu-Lassis M; Dromard M; Lacroix-Triki M; Nirdé P; Puech C; Knani D; Chalbos D; Freiss G
Cancer Res; 2010 Jun; 70(12):5116-26. PubMed ID: 20501847
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation.
Irie S; Hachiya T; Rabizadeh S; Maruyama W; Mukai J; Li Y; Reed JC; Bredesen DE; Sato TA
FEBS Lett; 1999 Oct; 460(2):191-8. PubMed ID: 10544233
[TBL] [Abstract][Full Text] [Related]
19. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ; Lin WC; Lin FT
J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]